240
Participants
Start Date
February 28, 2013
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
ABT-719
1 arm of ABT-719 higher dose, 1 arm of ABT-719 intermediate dose, and 1 arm ABT-719 lower dose
Placebo
Placebo infusion
Site Reference ID/Investigator# 109295, Copenhagen O
Site Reference ID/Investigator# 94955, Odense C
Site Reference ID/Investigator# 83722, New York
Site Reference ID/Investigator# 83734, Pittsburgh
Site Reference ID/Investigator# 83732, Bethesda
Site Reference ID/Investigator# 90614, Charlottesville
Site Reference ID/Investigator# 83725, Richmond
Site Reference ID/Investigator# 87733, Winston-Salem
Site Reference ID/Investigator# 83723, Durham
Site Reference ID/Investigator# 92413, Gastonia
Site Reference ID/Investigator# 89176, Asheville
Site Reference ID/Investigator# 87693, Atlanta
Site Reference ID/Investigator# 87717, Augusta
Site Reference ID/Investigator# 83746, Jacksonville
Site Reference ID/Investigator# 83733, Jacksonville
Site Reference ID/Investigator# 87720, Gainesville
Site Reference ID/Investigator# 89178, Tampa
Site Reference ID/Investigator# 83730, Knoxville
Site Reference ID/Investigator# 101876, Memphis
Site Reference ID/Investigator# 85917, Lexington
Site Reference ID/Investigator# 91813, Columbus
Site Reference ID/Investigator# 83738, Toledo
Site Reference ID/Investigator# 83735, Cincinnati
Site Reference ID/Investigator# 101942, Indianapolis
Site Reference ID/Investigator# 89180, Fort Wayne
Site Reference ID/Investigator# 83744, Royal Oak
Site Reference ID/Investigator# 83750, Grand Blanc
Site Reference ID/Investigator# 83747, Petoskey
Site Reference ID/Investigator# 87739, Milwaukee
Site Reference ID/Investigator# 91814, Madison
Site Reference ID/Investigator# 85913, Saint Paul
Site Reference ID/Investigator# 96455, St Louis
Site Reference ID/Investigator# 91693, Portland
Site Reference ID/Investigator# 89182, Springfield
Site Reference ID/Investigator# 87714, Tacoma
Site Reference ID/Investigator# 83739, Danbury
Site Reference ID/Investigator# 83724, Boston
Site Reference ID/Investigator# 83745, Boston
Site Reference ID/Investigator# 91253, Omaha
Site Reference ID/Investigator# 93673, Newark
Site Reference ID/Investigator# 94956, Aarhus N
Lead Sponsor
AbbVie
INDUSTRY